product Image
DiaPlexC™ MTC/NTM Detection Kit (Tuberculosis)
Model Name
-
Series
Molecular Diagnostic (Pathogen Detection)
Data
-
Manufacturer information
provider logo
SOLGENT

DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus

Problem with product info?
Update request
Manufacturer
SOLGENT
Brand
-
SKU
125207
Product Name
DiaPlexC™ MTC/NTM Detection Kit (Tuberculosis)
Model Name
-
Size
-
Weight
-
Product Details

DiaPlexC™ MTC/NTM Detection Kit

Multiplex PCR based assay system for simultaneous detection of MTC and NTM complex

CE-IVD


Mycobacterium tuberculosis (MTB) is a pathogenic bacteria species and the causative agent in most cases of tuberculosis. Along with MTB, 5 other species, which we call MTC are regarded as common infectious agents causing tuberculosis. That is why it is necessary to detect MTC, along with MTB. Although NTM is a group of non-tuberculosis related mycobacteria, it usually causes lung infections that mimic tuberculosis resulting in a potential misdiagnosis. Thus, the identification of a single infection or co-infection of MTC and NTM is required for appropriate treatment.




Specification


DiaPlexC™ MTC/NTM Detection Kit
Detection target
MTC (2 species), NTM (10 species)
Registration
CE-IVD
Detection technology
Conventional (End-point) Multiplex PCR
Specimen type
Nasopharyngeal swab, Nasopharyngeal aspirate, Bronchoalveolar lavage (BAL), Nasal swab, Oropharyngeal swab, Sputum
Analytical sensitivity
10² - 105 copies
Compatible instruments*
ABI Veriti thermal Cycler (Applied Biosystems) recommended
PCR running time
~ 1 hr 30 min




Features

- HotStart PCR system : Ultra high specific and sensitive result

- DnaFree™ system : No host genomic DNA contamination ( DiaPlexC ™)

- UDG system : No carryover contamination

- Multiplex PCR system : Multiple targets in a single reaction

- Reliable system : Automatic PCR control

- Positive control included

- DNA extraction solution included (Cat. No. SQD21-K100)

- Easy-to-use master mix

- CE certification




Experimental


LaneInterpretation (detection)
1NTM
2MTC
3MTC, NTM (Co-infection)
4Negative (or NTC)
5Required re-experiment



Citation&Papers

Korean J Clin microbial, Seong Deok Lee, Hye Young Lee, Hyun Chul Kim, Soo Young Kim,

Mycobacterium tuberculosis and Non-Tuberculous Mycobacteria by PCR Assay.

Ryan KJ, Ray CG (Editors) (2004).

Sherris Medical Microbiology (4th ed.). McGraw-Hill. Clinical Characteristics of Non-Tuberculous Mycobacterial Pulmonary Disease in a National Tuberculosis Hospital.

Sun-Pil Choi, M.D., Bong-Keun Lee M.D.1, Jin-Hong Min, M.D., Jin-Hee Kim, M.D.

pathogenic Classification and Clinical Characteristics of Non-Tuberculous Mycobacterial Pulmonary Disease in National Tuberculosis Hospital





Ordering information

TechnologyCat. No.ProductContents
Conventional (End-point) PCRSMD21-K020 (20 reaction)DiaPlexC ™ MTC/NTM Detection Kit2X Multiplex PCR Smart mix (with UDG) (MTC/NTM)
Primer Mixture (MTC/NTM)
Standard Marker (MTC/NTM)
Control Template (MTC/NTM)
Nuclease free Water
SMD21-K100 (100 reaction)









More products
SOLGENT
DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
For the past 19 years, SolGent grown as a company specialized in human molecular diagnostics projects. In celebration of its 20th anniversary, the company announced its vision of a new start, “SolGent 2.0” and is growing as a bio leader in the 4th Industrial Revolution. Sturdily amassed genome analysis technology and molecular diagnostic technology have become the prominent foundation of the molecular diagnostic market, and SolGent supply products and services with the highest quality to more than 25 countries including domestic research institutes, examination centers, medical institutions and universities. In particular, as “precision medicine,” which analyzes genomes to prevent and predict diseases, becomes a new medical paradigm, SolGent develops and supplies various genome analysis services including for cancer, and expands and applies these services to agricultural products to build the AG-BIO platform. Based on its innovative technology, SolGent develops NADPH coenzyme fixed quantity measurement products DiaPlexQ™ Novel Coronavirus (2019-nCoV) Detection Kit, Covid19, Corona virus
Inquiry